Please login to the form below

Not currently logged in
Email:
Password:

Research Pipeline

This page shows the latest Research Pipeline news and features for those working in and with pharma, biotech and healthcare.

CRUK forges £30m ‘post-Brexit’ R&D alliance

CRUK forges £30m ‘post-Brexit’ R&D alliance

No single organisation or country is going to beat cancer on its own, ”commented Dr Iain Foulkes, executive director of research and innovation at CRUK. ... Our Accelerator Award funding will lay the groundwork for a Europe and UK research pipeline,

Latest news

  • Daily Brief: GSK unveils R&D plan, Keytruda OK'd for lymphoma by NICE Daily Brief: GSK unveils R&D plan, Keytruda OK'd for lymphoma by NICE

    News from pharma, biotech and healthcare. 23andMe alliance part of GSK’s new research plan. ... GSK’s CEO Emma Walmsley (pictured) has restated her determination to revive the firm’s research pipeline in a statement this morning, ahead of an

  • GSK: we won’t be splitting up any time soon

    The company has 27 immunomodulatory new molecular entities (NME) in clinical trials, around 60% of its total clinical pipeline. ... GSK is investing $300m in the firm, and says a long-term partnership to exploit its genetic databases will help it advance

  • Daily brief: Novartis spends big on ezcema, Daily brief: Novartis spends big on ezcema,

    Novartis already has ZPL389 in its pipeline, a phase II ezcema treatment it gained with the acquisition of Ziarco two years ago. ... The company, based in London and New York, has four ongoing clinical programmes, one compassionate use programme and a

  • BenevolentAI claims AI first with new Cambridge facility BenevolentAI claims AI first with new Cambridge facility

    BenevolentAI claims AI first with new Cambridge facility. Says its new drug discovery and development base will cover the entire research process. ... The company has previously generated novel drug candidates to treat a range of complex and previously

  • Artificial intelligence firm licenses Janssen candidates for development Artificial intelligence firm licenses Janssen candidates for development

    Janssen has licensed a number of pipeline candidates to a UK artificial intelligence company that wants to use technology to innovate the drug development process. ... The London-based firm said the agreement would enable it to accelerate its development

More from news
Approximately 3 fully matching, plus 43 partially matching documents found.

Latest Intelligence

  • Heart failure therapy embarks on a new era Heart failure therapy embarks on a new era

    There are also a number of other drugs coming through the research pipelines. ... Pipeline growing. While Entresto and ivabradine promise to make a significant impact in HF, there are also a number of other investigational drugs coming through the

  • Eisai: Bucking the trend with R&D growth Eisai: Bucking the trend with R&D growth

    Research pipeline. Research at Eisai is focused on three key areas: neuroscience, oncology and vascular/immunological diseases. ... Commercial expansion. But it's not just in research spending that Eisai is bucking industry trends.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics